View Financial HealthMéthanor 배당 및 자사주 매입배당 기준 점검 0/6Méthanor 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률0%배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트Upcoming Dividend • Jun 29Upcoming dividend of €0.15 per share at 3.9% yieldEligible shareholders must have bought the stock before 06 July 2023. Payment date: 28 July 2023. Trailing yield: 3.9%. Lower than top quartile of French dividend payers (5.2%). Higher than average of industry peers (2.0%).Upcoming Dividend • Jul 06Upcoming dividend of €0.10 per shareEligible shareholders must have bought the stock before 13 July 2021. Payment date: 04 August 2021. Trailing yield: 2.0%. Lower than top quartile of French dividend payers (3.7%). Lower than average of industry peers (6.7%).모든 업데이트 보기Recent updatesNew Risk • Jun 27New major risk - Revenue and earnings growthEarnings have declined by 24% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$93k). Market cap is less than US$10m (€7.00m market cap, or US$8.19m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Buy Or Sell Opportunity • May 27Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 24% to €2.20. The fair value is estimated to be €2.78, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 65% over the last 3 years. Meanwhile, the company became loss making.New Risk • Apr 30New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended December 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2023 fiscal period end). Revenue is less than US$1m. Market cap is less than US$10m (€5.29m market cap, or US$6.01m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (11% average weekly change). Large one-off items impacting financial results.Valuation Update With 7 Day Price Move • Apr 23Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €2.21, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 18x in the Chemicals industry in France. Total loss to shareholders of 45% over the past three years.Buy Or Sell Opportunity • Apr 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.8% to €2.21. The fair value is estimated to be €2.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 100% over the last year. Earnings per share has declined by 81%.Valuation Update With 7 Day Price Move • Feb 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.91, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 21x in the Chemicals industry in France. Total loss to shareholders of 27% over the past three years.Buy Or Sell Opportunity • Jan 15Now 31% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.7% to €2.02. The fair value is estimated to be €2.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 100% over the last year. Earnings per share has declined by 81%.Valuation Update With 7 Day Price Move • Jan 14Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €2.35, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 20x in the Chemicals industry in France. Total loss to shareholders of 44% over the past three years.New Risk • Jan 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 9.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.9% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (€4.46m market cap, or US$4.62m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding).New Risk • Nov 22New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.1% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (€4.43m market cap, or US$4.61m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding).New Risk • Nov 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (€4.60m market cap, or US$4.86m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.1% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding).Buy Or Sell Opportunity • Aug 29Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to €2.28. The fair value is estimated to be €2.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 93% over the last 3 years. Earnings per share has grown by 30%.Buy Or Sell Opportunity • Aug 13Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to €2.34. The fair value is estimated to be €2.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 93% over the last 3 years. Earnings per share has grown by 30%.New Risk • Jun 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€5.87m market cap, or US$6.31m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.7% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding).공시 • May 26Méthanor SCA, Annual General Meeting, Jun 28, 2024Méthanor SCA, Annual General Meeting, Jun 28, 2024. Location: 24 rue de clichy, paris FranceNew Risk • Apr 05New major risk - Revenue and earnings growthEarnings have declined by 19% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€7.02m market cap, or US$7.61m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding).Buy Or Sell Opportunity • Mar 13Now 21% overvaluedOver the last 90 days, the stock has fallen 2.2% to €3.07. The fair value is estimated to be €2.55, however this is not to be taken as a sell recommendation but rather should be used as a guide only.New Risk • Jan 25New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 21% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (€80k revenue, or US$87k). Market cap is less than US$10m (€7.28m market cap, or US$7.94m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding).New Risk • Dec 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$86k). Market cap is less than US$10m (€6.38m market cap, or US$6.86m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.8% average weekly change). Large one-off items impacting financial results.Price Target Changed • Dec 08Price target decreased by 7.9% to €5.69Down from €6.18, the current price target is provided by 1 analyst. New target price is 81% above last closing price of €3.14. Stock is down 13% over the past year. The company is forecast to post earnings per share of €0.28 for next year compared to €0.64 last year.Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €3.40, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 13x in the Chemicals industry in France. Total loss to shareholders of 28% over the past three years.New Risk • Oct 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$85k). Market cap is less than US$10m (€6.11m market cap, or US$6.48m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.0% average weekly change). Large one-off items impacting financial results.Upcoming Dividend • Jun 29Upcoming dividend of €0.15 per share at 3.9% yieldEligible shareholders must have bought the stock before 06 July 2023. Payment date: 28 July 2023. Trailing yield: 3.9%. Lower than top quartile of French dividend payers (5.2%). Higher than average of industry peers (2.0%).Price Target Changed • May 09Price target increased by 7.3% to €6.16Up from €5.74, the current price target is provided by 1 analyst. New target price is 74% above last closing price of €3.54. Stock is down 16% over the past year. The company is forecast to post earnings per share of €0.57 next year compared to a net loss per share of €0.43 last year.공시 • Dec 23An unknown buyer acquired portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) for €1.9 million.An unknown buyer acquired portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) for €1.9 million on December 21, 2022. An unknown buyer completed the acquisition of portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) on December 21, 2022.Price Target Changed • Jan 03Price target decreased to €5.35Down from €5.85, the current price target is provided by 1 analyst. New target price is 30% above last closing price of €4.10. Stock is down 19% over the past year. The company is forecast to post earnings per share of €0.23 for next year compared to €0.11 last year.Valuation Update With 7 Day Price Move • Dec 27Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €4.05, the stock trades at a trailing P/E ratio of 32.9x. Average trailing P/E is 18x in the Oil and Gas industry in France. Total loss to shareholders of 4.3% over the past three years.Upcoming Dividend • Jul 06Upcoming dividend of €0.10 per shareEligible shareholders must have bought the stock before 13 July 2021. Payment date: 04 August 2021. Trailing yield: 2.0%. Lower than top quartile of French dividend payers (3.7%). Lower than average of industry peers (6.7%).Is New 90 Day High Low • Oct 26New 90-day low: €4.90The company is down 16% from its price of €5.80 on 28 July 2020. The French market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Oil and Gas industry, which is down 12% over the same period.Is New 90 Day High Low • Oct 08New 90-day low: €5.05The company is down 18% from its price of €6.15 on 10 July 2020. The French market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Oil and Gas industry, which is down 11% over the same period.Is New 90 Day High Low • Sep 23New 90-day low: €5.20The company is down 4.0% from its price of €5.40 on 25 June 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Oil and Gas industry, which is down 14% over the same period.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 ALMET 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: ALMET 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Méthanor 배당 수익률 vs 시장ALMET의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (ALMET)0%시장 하위 25% (FR)1.9%시장 상위 25% (FR)5.6%업계 평균 (Chemicals)2.2%분석가 예측 (ALMET) (최대 3년)0%주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 ALMET 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 ALMET 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: ALMET French 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: ALMET 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YFR 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/20 05:39종가2026/05/20 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Méthanor SCA는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Nicolas RoyotPortzamparc BNP Paribas
Upcoming Dividend • Jun 29Upcoming dividend of €0.15 per share at 3.9% yieldEligible shareholders must have bought the stock before 06 July 2023. Payment date: 28 July 2023. Trailing yield: 3.9%. Lower than top quartile of French dividend payers (5.2%). Higher than average of industry peers (2.0%).
Upcoming Dividend • Jul 06Upcoming dividend of €0.10 per shareEligible shareholders must have bought the stock before 13 July 2021. Payment date: 04 August 2021. Trailing yield: 2.0%. Lower than top quartile of French dividend payers (3.7%). Lower than average of industry peers (6.7%).
New Risk • Jun 27New major risk - Revenue and earnings growthEarnings have declined by 24% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$93k). Market cap is less than US$10m (€7.00m market cap, or US$8.19m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Buy Or Sell Opportunity • May 27Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 24% to €2.20. The fair value is estimated to be €2.78, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 65% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Apr 30New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended December 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2023 fiscal period end). Revenue is less than US$1m. Market cap is less than US$10m (€5.29m market cap, or US$6.01m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (11% average weekly change). Large one-off items impacting financial results.
Valuation Update With 7 Day Price Move • Apr 23Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €2.21, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 18x in the Chemicals industry in France. Total loss to shareholders of 45% over the past three years.
Buy Or Sell Opportunity • Apr 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.8% to €2.21. The fair value is estimated to be €2.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 100% over the last year. Earnings per share has declined by 81%.
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.91, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 21x in the Chemicals industry in France. Total loss to shareholders of 27% over the past three years.
Buy Or Sell Opportunity • Jan 15Now 31% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.7% to €2.02. The fair value is estimated to be €2.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 100% over the last year. Earnings per share has declined by 81%.
Valuation Update With 7 Day Price Move • Jan 14Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €2.35, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 20x in the Chemicals industry in France. Total loss to shareholders of 44% over the past three years.
New Risk • Jan 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 9.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.9% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (€4.46m market cap, or US$4.62m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding).
New Risk • Nov 22New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.1% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (€4.43m market cap, or US$4.61m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding).
New Risk • Nov 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (€4.60m market cap, or US$4.86m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.1% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding).
Buy Or Sell Opportunity • Aug 29Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to €2.28. The fair value is estimated to be €2.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 93% over the last 3 years. Earnings per share has grown by 30%.
Buy Or Sell Opportunity • Aug 13Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to €2.34. The fair value is estimated to be €2.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 93% over the last 3 years. Earnings per share has grown by 30%.
New Risk • Jun 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€5.87m market cap, or US$6.31m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.7% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding).
공시 • May 26Méthanor SCA, Annual General Meeting, Jun 28, 2024Méthanor SCA, Annual General Meeting, Jun 28, 2024. Location: 24 rue de clichy, paris France
New Risk • Apr 05New major risk - Revenue and earnings growthEarnings have declined by 19% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€7.02m market cap, or US$7.61m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding).
Buy Or Sell Opportunity • Mar 13Now 21% overvaluedOver the last 90 days, the stock has fallen 2.2% to €3.07. The fair value is estimated to be €2.55, however this is not to be taken as a sell recommendation but rather should be used as a guide only.
New Risk • Jan 25New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 21% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (€80k revenue, or US$87k). Market cap is less than US$10m (€7.28m market cap, or US$7.94m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding).
New Risk • Dec 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$86k). Market cap is less than US$10m (€6.38m market cap, or US$6.86m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.8% average weekly change). Large one-off items impacting financial results.
Price Target Changed • Dec 08Price target decreased by 7.9% to €5.69Down from €6.18, the current price target is provided by 1 analyst. New target price is 81% above last closing price of €3.14. Stock is down 13% over the past year. The company is forecast to post earnings per share of €0.28 for next year compared to €0.64 last year.
Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €3.40, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 13x in the Chemicals industry in France. Total loss to shareholders of 28% over the past three years.
New Risk • Oct 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$85k). Market cap is less than US$10m (€6.11m market cap, or US$6.48m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.0% average weekly change). Large one-off items impacting financial results.
Upcoming Dividend • Jun 29Upcoming dividend of €0.15 per share at 3.9% yieldEligible shareholders must have bought the stock before 06 July 2023. Payment date: 28 July 2023. Trailing yield: 3.9%. Lower than top quartile of French dividend payers (5.2%). Higher than average of industry peers (2.0%).
Price Target Changed • May 09Price target increased by 7.3% to €6.16Up from €5.74, the current price target is provided by 1 analyst. New target price is 74% above last closing price of €3.54. Stock is down 16% over the past year. The company is forecast to post earnings per share of €0.57 next year compared to a net loss per share of €0.43 last year.
공시 • Dec 23An unknown buyer acquired portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) for €1.9 million.An unknown buyer acquired portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) for €1.9 million on December 21, 2022. An unknown buyer completed the acquisition of portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) on December 21, 2022.
Price Target Changed • Jan 03Price target decreased to €5.35Down from €5.85, the current price target is provided by 1 analyst. New target price is 30% above last closing price of €4.10. Stock is down 19% over the past year. The company is forecast to post earnings per share of €0.23 for next year compared to €0.11 last year.
Valuation Update With 7 Day Price Move • Dec 27Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €4.05, the stock trades at a trailing P/E ratio of 32.9x. Average trailing P/E is 18x in the Oil and Gas industry in France. Total loss to shareholders of 4.3% over the past three years.
Upcoming Dividend • Jul 06Upcoming dividend of €0.10 per shareEligible shareholders must have bought the stock before 13 July 2021. Payment date: 04 August 2021. Trailing yield: 2.0%. Lower than top quartile of French dividend payers (3.7%). Lower than average of industry peers (6.7%).
Is New 90 Day High Low • Oct 26New 90-day low: €4.90The company is down 16% from its price of €5.80 on 28 July 2020. The French market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Oil and Gas industry, which is down 12% over the same period.
Is New 90 Day High Low • Oct 08New 90-day low: €5.05The company is down 18% from its price of €6.15 on 10 July 2020. The French market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Oil and Gas industry, which is down 11% over the same period.
Is New 90 Day High Low • Sep 23New 90-day low: €5.20The company is down 4.0% from its price of €5.40 on 25 June 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Oil and Gas industry, which is down 14% over the same period.